An academic consortium led by UC Davis' Clinical and Translational Science Center is creating the Pharmaceutical Assets Portal that will allow scientists to learn about existing drugs that could be used in treating diseases and conditions other than the one they were originally intended to target. In addition to UC Davis, the consortium includes the University of Washington, Oregon Health and Sciences University, University of Pennsylvania, and the University of Chicago. The team is collaborating with industry, including the Virginia-based technology company Biovista, which provided initial data for the portal. For more information about the portal site, visit www.ctsapharmaportal.org.